Re:Norepinephrine-mediated slow vasomotion drives glymphatic...
by ajmurmann on Wednesday January 15, 2025 @10:45AM
(#42712262)
Seems like this is an issue for the company that makes Ambien but an opportunity for everyone else in that industry (and for patients)
[ Parent
| on HN ]
There are no comments on this comment yet.